Sichuan, China

Meiling Zhou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Yaopharma Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meiling Zhou. Retrieved from https://idiyas.com/inventor/meiling-zhou-4pm4timp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meiling Zhou: Innovator in Pharmaceutical Chemistry

Introduction

Meiling Zhou is a prominent inventor based in Sichuan, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Meiling Zhou holds a patent for a podophyllotoxin derivative with 4-position nitrogen substitution. This patent describes a compound represented by a specific formula or a pharmaceutically acceptable salt thereof. The formulation prepared using this compound exhibits significantly higher buildup and concentration in the lungs compared to other tissues. Additionally, it demonstrates a longer dwell time in the lungs and elevated pharmaceutical efficacy.

Career Highlights

Zhou is associated with Yaopharma Co., Ltd., where she applies her expertise in developing pharmaceutical solutions. Her work has been instrumental in advancing the understanding of drug delivery systems and improving therapeutic outcomes.

Collaborations

Meiling Zhou collaborates with notable colleagues, including Zhirong Zhang and Yan Zhang. Their combined efforts contribute to the innovative research environment at Yaopharma Co., Ltd.

Conclusion

Meiling Zhou's contributions to pharmaceutical chemistry through her innovative patents and collaborative efforts highlight her role as a key inventor in the field. Her work continues to impact the development of effective therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…